Viral hepatitis in the context of HIV in South-East Asia Region
Other Titlesreport of an informal consultation, New Delhi, 7-9 June 2010
AbstractViral hepatitis is a serious global public health problem. About 2 billion people worldwide are infected with hepatitis B virus, leading to ~600 000 deaths/year. Approximately 130-170 million are chronically infected with hepatitis C virus, resulting in >350 000 deaths/year. In addition, 50-100% of HIV-positive injecting drug users are coinfected with the hepatitis C virus. In coinfected persons, the course of hepatitis is affected by HIV and there may be faster progression to liver cirrhosis, and higher rates of mortality. In Asia, injecting drug users have higher rates of hepatitis. The endemicity of hepatitis B virus is about 10%, and hepatitis C virus <5%. The prevalence of HBV and HCV among people living with HIV (PLHIV) is usually underestimated. WHO SEARO convened an informal consultation on "Viral Hepatitis in the context of HIV and the way forward" from 7 to 9 June 2010 in New Delhi. The aim of the consultation was to review the current situation of viral hepatitis in the Region, identify mechanisms for the prevention and control of hepatitis, and suggest the way forward. This reports documents the discussions and recommendations of the consultation.
World Health Organization, Regional Office for South-East Asia. (2010). Viral hepatitis in the context of HIV in South-East Asia Region. WHO Regional Office for South-East Asia. https://apps.who.int/iris/handle/10665/206519